Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hygiene hypothesis wikipedia , lookup
Urinary tract infection wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Schistosomiasis wikipedia , lookup
Hepatitis B wikipedia , lookup
Marburg virus disease wikipedia , lookup
Neonatal infection wikipedia , lookup
Hepatitis C wikipedia , lookup
Med. Mycol. J. Med. Mycol. J. Vol. 55(No. 3) , 2014 Vol. 55E, E 51 − E 54, 2014 ISSN 2185 − 6486 E 51 Short Report Cryptococcus gattii genotype VGIIb infection in Japan ઃ અ Ichiro Kawamura , Katsuhiko Kamei , Kyoko Yarita , Misako Ohkusu , Kenta Ito , ઃ આ ઇ ઈ Mika Tsukahara , Masatake Honda , Kazuhisa Nakashima , Hiroaki Akamatsu , ઃ Hanako Kurai Division of Infectious Diseases, Shizuoka Cancer Center Hospital Medical Mycology Research Center, Chiba University " Department of Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital ' Pathology Division, Shizuoka Cancer Center Hospital ) Division of Thoracic Oncology, Shizuoka Cancer Center Hospital + Third Department of Internal Medicine, Wakayama Medical University ABSTRACT This report describes a case of Cryptococcus gattii VGIIb infection of the pulmonary and central nervous systems in an immunocompetent Japanese man with a travel history, and it hypothesizes the place where he was infected with C. gattii using the genotype information. Key words:cryptococcosis, Cryptococcus gattii, genotype VGIIb Introduction Cryptococcus gattii causes a life-threatening infection of the pulmonary and central nervous systems and has traditionally been considered to be geographically restricted to the tropical and subtropical regions of the world. However, an outbreak in the Pacific Northwest of North America has changed our understanding of the 1) epidemiology of C. gattii infection . Sporadic cases have also been documented in other regions, including areas in Europe, Asia, Africa, 2, 3) and South America . These reports have demonstrated a much less restrictive geographic range for C. gattii than previously thought. There are four genotypes of C. gattii, VGI to VGIV, each containing subtypes as determined by several genotyping techniques. Genotypes VGI and VGII are prevalent worldwide, while VGIII and 3) VGIV are less common . VG genotypes indicate that their distribution and frequency vary among Address for correspondence : Ichiro Kawamura Division of Infectious Diseases, Shizuoka Cancer Center Hospital Received : 18, April 2014. Accepted : 6, June 2014 [email protected] different geographic regions, although further studies are needed to explain possible connections between the distributions of various genotypes. Since 2001, Japanese cases of C. gattii infection 4−6) have sporadically been reported . This report describes a case of C. gattii VGIIb infection of the pulmonary and central nervous systems in an immunocompetent Japanese man with a travel history, and it hypothesizes the place where he was infected with C. gattii using the genotype information. Case A previously healthy 41-year-old Japanese male was referred to the Shizuoka Cancer Center for a left lung mass. He complained of fever, cough, and headaches for two months. Six months before his symptoms started, he had traveled to Nanjing in China for one week. Additional travel history included trips to Hong Kong and Shanghai in E 52 Medical Mycology Journal Volume 55, Number 3, 2014 Fig. 1.Contrast-enhanced chest computed tomography revealed a large consolidated mass in the left lower lobe, accompanied by mediastinal lymphadenopathy. Fig. 2.Axial gadolinium-enhanced FLAIR showed a small enhancing nodule(arrow)within the temporal lobe. FLAIR, fluid-attenuated inversion recovery. China, as well as Hawaii in the United States during his twenties. He was an office worker who had not been exposed to imported timber or animals. Examination upon hospital admission revealed wheezes in his left lung. Chest computed tomography revealed a large consolidated mass in the lower left lung lobe(Fig. 1) . Transbronchial biopsy demonstrated numerous fungal elements observed as encapsulated yeast with clear halos, a characteristic of Cryptococcus spp. A Cryptococcus sp. was later cultured from bronchoalveolar lavage fluid. Magnetic resonance imaging of the brain showed multiple small nodules throughout the cerebral parenchyma(Fig. 2). Lumbar puncture had a normal opening pressure at 19 cm H2 O, and the cerebrospinal fluid contained 276 nucleated cells, 84% of which were lymphocytes; no Cryptococcus spp. were isolated. Anti-HIV and anti-HTLV-1 antibody tests were negative. The cryptococcal strain isolated from the bronchoalveolar lavage was identified as C. gattii by analyzing the sequences of the internal trans7) cribed spacer regions . Multi-locus sequence typing(MLST)based on the sequence analysis of a set of polymorphic loci revealed that the isolate 8) was molecular type VGIIb . After eight weeks of liposomal amphotericin B treatment, along with six weeks of flucytosine therapy, the patient began consolidation therapy with 800 mg of oral fluconazole daily for eight weeks, followed by maintenance therapy with 400 mg fluconazole daily for an anticipated 16-month 9, 10) course . One year after the initiation of antifun- gal therapy, the patient was asymptomatic and appeared healthy. Discussion We described a case of C. gattii genotype VGIIb infection in a Japanese male with a travel history to several cities in China and Hawaii. In 2001, Tsunemi et al. reported the first Japanese case in a healthy 71-year-old physician who had traveled 4) to Australia for one week . Okamoto et al. reported a genotype VGIIa case in an immunocompetent 44-year-old sign painter who had 5) traveled to Guam and Saipan . To the best of our knowledge, genotype VGIIb was first detected in clinical specimens from Japan. VGII has been reported in the Western Hemisphere, Australasia, Asia, and Africa and is reportedly the most common and virulent strain responsible for infections in healthy and immuno3) compromised hosts . This strain is also associated with an ongoing outbreak of C. gattii cryptococcosis in Vancouver Island, British Col1) umbia, Canada . These outbreak-related isolates have been genotyped as VGIIa, the major genoty1, 11) pe, or VGIIb, the minor genotype . Additionally, a unique genotype, VGIIc, was recovered in Oregon in the United States. In this study, the MLST analysis was performed to determine the genetic relationship between the isolate and other various geographic strains. Overall, the sequence type of the isolate was ST7(sequence type 7) based on the Fungal MLST database(http://mlst. mycologylab. org) ; it was identical to the se- E 53 Med. Mycol. J. Vol. 55(No. 3) , 2014 quence type of the Vancouver Island minor genotype strain R272(VGIIb) . Although a small number of C. gattii cases have been documented 12, 13) in Hawaii, VGIIb has not been reported there . However, several molecular epidemiological studies have suggested that VGI is the most common genotype in China, with VGIIb being less common 14, 15) among C. gattii infections there . Since Australian eucalypts were first reported in 1990 as natural habitats for Cryptococcus 16) spp. , C. gattii has been isolated from more than 50 tree species, including angiosperms and 3) gymnosperms . C. gattii has also been associated with native animals in Australia(koalas, echidnas),New Zealand(kiwi) , Africa(cheetahs) , and 3) Canada(squirrels) . The first reported Japanese case had close contact with koalas when travell4) ing to Australia . In Japan, no studies have reported isolation of C. gattii from the environment, although koalas kept in two different zoos 17, 18) were carriers of this pathogen . Additionally, there have been no reports on the epidemiology of C. gattii genotypes in China, including their environmental profiles. Understanding the length of the incubation period is critical to track the acquisition of C. gattii. A study of seven travelers to Vancouver Island revealed that incubation periods ranged from two to eleven months, with a median of six to 19) seven months . Other reports indicated a longer incubation period of several years following likely exposure, which suggests that C. gattii may be 20−22) able to remain dormant . Thus, the incubation period of C. gattii remains uncertain and needs more investigation. Our patient had no exposure to imported timber or animals while living in Japan, and there have been only a few C. gattii clinical cases and no isolation of C. gattii from environmental niches in that country. Our patient had previously visited China three times and Hawaii once, and as previously mentioned, infections with the VGIIb C. 14, 15) gattii genotype have been reported in China . Thus, the source of his infection appears to have originated in China, although we cannot rule out the possibility that he was infected in Japan. We acknowledge the limitation to infer the source of his infection from the MLST analysis because of a lack of comprehensive environmental and clinical surveillance samples from areas where the patient resides or traveled. Genotype information 23) is not essential in routine clinical practice ; however, in terms of epidemiologic investigation, genotyping may be helpful for estimating where a patient was infected or for surveying which strains are common in a region. References 1)Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, Macdougall L, Boekhout T, KwonChung KJ, Meyer W: A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island(British Columbia, Canada) . Proc Natl Acad Sci USA 101: 17258-17263, 2004. 2)Harris J, Lockhart S, Chiller T: Cryptococcus gattii: where do we go from here? Med Mycol 50: 113-129, 2012. 3)Springer DJ, Chaturvedi V: Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis 16: 14-20, 2010. 4) Tsunemi T, Kamata T, Fumimura Y, Watanabe M, Yamawaki M, Saito Y, Kanda T, Ohashi K, Suegara N, Murayama S, Makimura K, Yamaguchi H, Mizusawa H: Immunohistochemical diagnosis of Cryptococcus neoformans var. gattii infection in chronic meningoencephalitis: the first case in Japan. Intern Med 40: 1241-1244, 2001. 5)Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, Kitazawa T, Yotsuyanagi H, Ikeda R, Sugita T, Koike K: Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 16: 1155-1157, 2010. 6) Horiuchi K, Yamada M, Shirai S, Takahashi I, Kano T, Kaneko Y, Akizawa K, Umeyama T, Miyazaki Y, Yabe I, Sasaki H: A case of successful treatment of brain and lung cryptococcosis caused by Cryptococcus gattii. Rinsho Shinkeigaku 52: 166171, 2012. 7)Katsu M, Kidd S, Ando A, Moretti-Branchini ML, Mikami Y, Nishimura K, Meyer W: The internal transcribed spacers and 5. 8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Res 4: 377-388, 2004. 8)Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, Fisher M, Gilgado F, Hagen F, Kaocharoen S, Litvintseva AP, Mitchell TG, Simwami SP, Trilles L, Viviani MA, Kwon-Chung J: Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 47: 561-570, 2009. 9)Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC: Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 50: 291-322, 2010. E 54 10)Chen SC, Korman TM, Slavin MA, Marriott D, Byth K, Bak N, Currie BJ, Hajkowicz K, Heath CH, Kidd S, McBride WJ, Meyer W, Murray R, Playford EG, Sorrell TC: Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis 57: 543-551, 2013. 11) Byrnes EJ, 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J: Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 199: 1081-1086, 2009. 12) Lockhart SR, Iqbal N, Harris JR, Grossman NT, DeBess E, Wohrle R, Marsden-Haug N, Vugia DJ: Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. PLoS One 8: e74737, 2013. 13)Harris JR, Lockhart SR, Sondermeyer G, Vugia DJ, Crist MB, DK Angelo MT, Sellers B, Franco-Paredes C, Makvandi M, Smelser C, Greene J, Stanek D, Signs K, Nett RJ, Chiller T, Park BJ: Cryptococcus gattii Infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis 19: 16211627, 2013. 14)Chen M, Pan WH, Boekhout T: Cryptococcus gattii infections in China: extent of the problem? Chin Med J(Engl)126: 203-205, 2013. 15)Feng X, Wu J, Ling B, Ren D, Yao Z: Molecular and phenotypic characterization of a VGII genotype Cryptococcus gattii XH91 isolated in China. Wei Sheng Wu Xue Bao 50: 1460-1465, 2010. 16)Ellis DH, Pfeiffer TJ: Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 28: 1642-1644, 1990. 17)Makimura K, Karasawa M, Hosoi H, Kobayashi T, Kamijo N, Kobayashi K, Hiramatsu H, Akikawa T, Medical Mycology Journal Volume 55, Number 3, 2014 Yabe T, Yamaguchi A, Ishida O, Murakami A, Fujisaki R, Nishiyama Y, Uchida K, Yamaguchi H: A Queensland koala kept in a Japanese zoological park was carrier of an imported fungal pathogen, Filobasidiella neoformans var. bacillispora(Cryptococcus neoformans var. gattii) . Jpn J Infect Dis 55: 31-32, 2002. 18)Kido N, Makimura K, Kamegaya C, Shindo I, Shibata E, Omiya T, Yamamoto Y: Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas(Phascolarctes cinereus) . Med Mycol 50: 291-298, 2012. 19)MacDougall L, Fyfe M: Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 44: 1851-1852, 2006. 20)Bottone EJ, Kirschner PA, Salkin IF: Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J Clin Microbiol 23: 186-188, 1986. 21)Castrodale LJ, Gerlach RF, Preziosi DE, Frederickson P, Lockhart SR: Prolonged incubation period for Cryptococcus gattii infection in cat, Alaska, USA. Emerg Infect Dis 19: 1034-1035, 2013. 22)Dromer F, Ronin O, Dupont B: Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J Med Vet Mycol 30: 395-397, 1992. 23)Rolston KV: Editorial commentary: cryptococcosis due to Cryptococcus gattii. Clin Infect Dis 57: 552-554, 2013.